Atlas Trials

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Clinical trial NCT00958269 · TERMINATED

Trial details

NCT number
NCT00958269
Sponsor
Phenomix
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusRenal Impairment
Start date
2009-08-01
Primary completion
2011-09-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.